Euro-Med Laboratories PhilippinesPHS:EURO 84 Dividend Yield % is 6.48% as of Jun. 25, 2026, which is 143% above its 10-year median of 2.67. GuruFocus rates PHS:EURO with a GF Score™ of 84/100 and a GF Value™ of ₱1.02 (Fairly Valued). The stock has 6 warning signs investors should review. Among 516 Drug Manufacturers companies, Euro-Med Laboratories Philippines ranks better than 95.74% on this metric.
During the past 13 years, the highest Dividend Payout Ratio of Euro-Med Laboratories Philippines was 1.02. The lowest was 0.40. And the median was 0.66.
During the past 12 months, Euro-Med Laboratories Philippines's average Dividends Per Share Growth Rate was 16.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 51.80% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 20.10% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -1.80% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Euro-Med Laboratories Philippines was 58.70% per year. The lowest was -34.10% per year. And the median was 0.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PHS:EURO vs ZTS, UTHR, VTRS: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Euro-Med Laboratories Philippines Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Euro-Med Laboratories Philippines's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Euro-Med Laboratories Philippines Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
PHP 0.070000
2025-11-13
2025-11-14
2025-12-01
Cash Dividend
annually
PHP:PHP 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Euro-Med Laboratories Philippines (PHS:EURO) has a Dividend Yield % of 6.48% as of Jun. 25, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Euro-Med Laboratories Philippines and its competitors. This is 143% above median its historical median of 2.67. Over the past decade, Euro-Med Laboratories Philippines' Dividend Yield % has ranged from 1.00 to 7.79. According to the industry distribution chart, Euro-Med Laboratories Philippines ranks #22 out of 516 companies in the Drug Manufacturers industry, placing it in the top 4.3%.
Is Euro-Med Laboratories Philippines' Dividend Yield % too high?
Euro-Med Laboratories Philippines' current Dividend Yield % of 6.48% is 143% above median its 10-year median of 2.67. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 7.79. The Drug Manufacturers industry median Dividend Yield % is 2.01. Euro-Med Laboratories Philippines' value of 6.48% is 223.2% above this industry median. Based on the distribution chart, Euro-Med Laboratories Philippines ranks #22 out of 516 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Euro-Med Laboratories Philippines ranks #22 out of 516 companies for Dividend Yield %. This places Euro-Med Laboratories Philippines in the top 4% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 2.01. Euro-Med Laboratories Philippines' value of 6.48% is 223.2% above this benchmark. Historically, Euro-Med Laboratories Philippines' own Dividend Yield % has ranged from 1.00 to 7.79 over the past decade. While the company's 10-year median is 2.67 vs. the industry median of 2.01, Euro-Med Laboratories Philippines has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.01, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Euro-Med Laboratories Philippines's current Dividend Yield % of 6.48% is 223.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Euro-Med Laboratories Philippines and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Euro-Med Laboratories Philippines's current Dividend Yield % is 6.48%, which is 143% above median its own 10-year median of 2.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.02, compared to a current price of ₱1.08 — trading 5.9% above its estimated fair value. The current Dividend Yield % is 6.48%, which is 143% above median its 10-year median of 2.67 and 223.2% above the Drug Manufacturers industry median of 2.01. Euro-Med Laboratories Philippines' overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current Dividend Yield % is 6.48% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued.
The current stock price of ₱1.08 is trading 5.9% above its estimated GF Value™ of ₱1.02.
GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.
Key valuation signals for PHS:EURO:
Dividend Yield %: 6.48% (143% above median its 10-year median of 2.67)
GF Value™: ₱1.02 vs. price of ₱1.08 (5.9% above fair value)
Industry Position: 223.2% above the Drug Manufacturers median (#22 of 516)
No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Euro-Med Laboratories Philippines Business Description
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
84GF Score
Get the complete analysis for PHS:EURO
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHS:EURO has been successfully added to your 
